Cyclacel Pharmaceuticals, Inc. (BGMS)
NASDAQ
Cyclacel Pharmaceuticals, Inc. Gross Margin 2024–2025
Current and historical gross margin for Cyclacel Pharmaceuticals, Inc. (BGMS) over the last 10 years. The current gross profit margin for Cyclacel Pharmaceuticals, Inc. as of December 31, 2025 is 18.47%.
From: 12/31/2024To: 12/31/2025
Revenue
Gross Profit
Gross Margin
Cyclacel Pharmaceuticals, Inc. Gross Margin — FAQ
Cyclacel Pharmaceuticals, Inc. (BGMS) gross margin over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Cyclacel Pharmaceuticals, Inc.'s gross margin?
Cyclacel Pharmaceuticals, Inc. (BGMS) reported gross margin of 18.5% for fiscal 2025.
Where can I see BGMS's gross margin history?
The chart and table above show Cyclacel Pharmaceuticals, Inc.'s gross margin by year and by quarter, including the growth rate.